Effects of Combination Treatment of Intravesical Resiniferatoxin Instillation and Hydrodistention in Patients with Refractory Painful Bladder Syndrome/Interstitial Cystitis: A Pilot Study
Byeong Kuk Ham, Jae Heon Kim, Mi Mi Oh, Jeong Gu Lee, Jae Hyun Bae
Int Neurourol J. 2012;16(1):41-46.   Published online 2012 Mar 31     DOI: https://doi.org/10.5213/inj.2012.16.1.41
Citations to this article as recorded by Crossref logo
Intravesical treatment for interstitial cystitis/painful bladder syndrome: a network meta-analysis
Wei Zhang, Xiaojing Deng, Chunyu Liu, Xu Wang
International Urogynecology Journal.2017; 28(4): 515.     CrossRef
Effective treatment of ketamine-associated cystitis with botulinum toxin type a injection combined with bladder hydrodistention
Jianfeng Zeng, Haibiao Lai, Dongxiang Zheng, Liang Zhong, Zhifeng Huang, Shanyun Wang, Weiwei Zou, Lianbo Wei
Journal of International Medical Research.2017; 45(2): 792.     CrossRef
Receptors, channels and signalling in the urothelial sensory system in the bladder
Liana Merrill, Eric J. Gonzalez, Beatrice M. Girard, Margaret A. Vizzard
Nature Reviews Urology.2016; 13(4): 193.     CrossRef
Transient receptor potential channel modulators as pharmacological treatments for lower urinary tract symptoms (LUTS): myth or reality?
Yves Deruyver, Thomas Voets, Dirk De Ridder, Wouter Everaerts
BJU International.2015; 115(5): 686.     CrossRef
Intravesical hyaluronic acid treatment for ketamine-associated cystitis: Preliminary results
En Meng, Chih-Wei Tsao, Shou-Hung Tang, Sheng-Tang Wu, Tai-Lung Cha, Guang-Huan Sun, Dah-Shyong Yu, Sun-Yran Chang
Urological Science.2015; 26(3): 176.     CrossRef
Pretreatment Features to Influence Effectiveness of Intravesical Hyaluronic Acid Instillation in Refractory Interstitial Cystitis/Painful Bladder Syndrome
Aram Kim, Bumjin Lim, Miho Song, Myung-Soo Choo
International Neurourology Journal.2014; 18(3): 163.     CrossRef
Challenges and current evidence on the management of bladder pain syndrome
Eleftheria L. Chrysanthopoulou, Stergios K. Doumouchtsis
Neurourology and Urodynamics.2014; 33(8): 1193.     CrossRef
TRP channels in lower urinary tract dysfunction
J Franken, P Uvin, D De Ridder, T Voets
British Journal of Pharmacology.2014; 171(10): 2537.     CrossRef
Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva)
Nissar A. Darmani, Seetha Chebolu, Weixia Zhong, Chung Trinh, Bryan McClanahan, Rajivinder S. Brar
European Journal of Pharmacology.2014; 722: 147.     CrossRef
Efficacy and safety of augmentation ileocystoplasty combined with supratrigonal cystectomy for the treatment of refractory bladder pain syndrome/interstitial cystitis with Hunner's lesion
Hyung Joon Kim, Jae Seong Lee, Won Jin Cho, Hyo Serk Lee, Ha Na Lee, Hyun Wook You, Wonho Jung, Kyu-Sung Lee
International Journal of Urology.2014; 21: 69.     CrossRef
TRPV1 dans les neuropathies douloureuses
Aurore Danigo, Laurent Magy, Claire Demiot
médecine/sciences.2013; 29(6-7): 597.     CrossRef
Long-term treatment outcomes in patients with interstitial cystitis/painful bladder syndrome: 10-year experience in NCKUH
Chien-Ying Wu, I-Hung Chen, Yat-Ching Tong
Urological Science.2013; 24(1): 10.     CrossRef
Die Versorgungssituation von Patienten mit interstitieller Zystitis in Deutschland
D. Jocham, G. Froehlich, F. Sandig, A. Ziegler
Der Urologe.2013; 52(5): 691.     CrossRef
Intravesical Resiniferatoxin for the Treatment of Storage Lower Urinary Tract Symptoms in Patients with Either Interstitial Cystitis or Detrusor Overactivity: A Meta-Analysis
Changcheng Guo, Bin Yang, Wenyu Gu, Bo Peng, Shengqiang Xia, Fengqiang Yang, Deyi Wen, Jiang Geng, Yuanyuan Zhang, Junhua Zheng, Robert Hurst
PLoS ONE.2013; 8(12): e82591.     CrossRef
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Clinical Investigation.2012; 2(11): 1085.     CrossRef